Impact of COVID-19 pandemic on pharmacologic treatment of patients newly diagnosed with osteoporosis
Description
CONCLUSIONS: This is the first study assessing COVID-19's impact on pharmacologic treatment of newly diagnosed osteoporosis. 40.5% of newly diagnosed patients were treated pharmacologically within six months of diagnosis, and the pandemic did not
